ZA200005189B - Stable dosage forms of fluoxetine and its enantiomers. - Google Patents

Stable dosage forms of fluoxetine and its enantiomers.

Info

Publication number
ZA200005189B
ZA200005189B ZA200005189A ZA200005189A ZA200005189B ZA 200005189 B ZA200005189 B ZA 200005189B ZA 200005189 A ZA200005189 A ZA 200005189A ZA 200005189 A ZA200005189 A ZA 200005189A ZA 200005189 B ZA200005189 B ZA 200005189B
Authority
ZA
South Africa
Prior art keywords
fluoxetine
enantiomers
dosage forms
stable dosage
stable
Prior art date
Application number
ZA200005189A
Other languages
English (en)
Inventor
Martin P Redmon
Halt Butler
Stephen A Wald
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of ZA200005189B publication Critical patent/ZA200005189B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA200005189A 1998-03-27 2000-09-27 Stable dosage forms of fluoxetine and its enantiomers. ZA200005189B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/049,227 US20030013740A1 (en) 1998-03-27 1998-03-27 Stable dosage forms of fluoxetine and its enantiomers

Publications (1)

Publication Number Publication Date
ZA200005189B true ZA200005189B (en) 2001-05-22

Family

ID=21958714

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200005189A ZA200005189B (en) 1998-03-27 2000-09-27 Stable dosage forms of fluoxetine and its enantiomers.

Country Status (11)

Country Link
US (1) US20030013740A1 (pt)
EP (1) EP1067918A1 (pt)
JP (1) JP2002509882A (pt)
KR (1) KR20010034703A (pt)
CN (1) CN1303280A (pt)
AU (1) AU3205399A (pt)
BR (1) BR9909118A (pt)
CA (1) CA2325858A1 (pt)
NO (1) NO20004818L (pt)
WO (1) WO1999049857A1 (pt)
ZA (1) ZA200005189B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6372919B1 (en) * 2001-01-11 2002-04-16 Dov Pharmaceutical, Inc. (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent
US6310251B1 (en) 2001-01-31 2001-10-30 Grayson Walker Stowell Form a of fluoxetine hydrochloride
US6310250B1 (en) 2001-01-31 2001-10-30 Grayson Walker Stowell Form A of fluoxetine hydrochloride
US6316672B1 (en) 2001-01-31 2001-11-13 Grayson Walker Stowell Form a of fluoxetine hydrochloride
US6313350B1 (en) 2001-01-31 2001-11-06 Grayson Walker Stowell Form a of fluoxetine hydrochloride
US6258853B1 (en) 2001-01-31 2001-07-10 Grayson Walker Stowell Form a of fluoxetine hydrochloride
US20070043100A1 (en) 2005-08-16 2007-02-22 Hagen Eric J Novel polymorphs of azabicyclohexane
US20080045725A1 (en) 2006-04-28 2008-02-21 Murry Jerry A Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
NZ619413A (en) 2006-05-04 2015-08-28 Boehringer Ingelheim Int Polymorphs of a dpp-iv enzyme inhibitor
AR071175A1 (es) 2008-04-03 2010-06-02 Boehringer Ingelheim Int Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
WO2010094471A1 (en) 2009-02-17 2010-08-26 Krka, D. D., Novo Mesto Pharmaceutical compositions comprising prasugrel base or its pharmaceutically acceptable acid addition salts and processes for their preparation
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
JP5952912B2 (ja) 2011-12-15 2016-07-13 アルカーメス ファーマ アイルランド リミテッド 二級アミン化合物のプロドラッグ
MX2015016589A (es) * 2015-12-02 2017-06-01 Samuel CHAIT AUERBACH Jaime Composicion oral veterinaria con gabapentina.
CN107334744B (zh) * 2017-07-24 2020-09-04 湖南洞庭药业股份有限公司 盐酸美金刚药物组合物和制法
CN107334742B (zh) * 2017-08-18 2020-01-31 山东力诺制药有限公司 一种盐酸氟西汀分散片及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4594358A (en) * 1985-02-25 1986-06-10 Eli Lilly And Company Analgesic method
CH678920A5 (pt) * 1989-11-14 1991-11-29 Gergely Gerhard
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
DE69728857T3 (de) * 1996-02-09 2010-02-18 Quadrant Drug Delivery Ltd., Ruddington Feste arzneimittel enthaltend trehalose
EP0792649A1 (en) * 1996-02-29 1997-09-03 Eli Lilly And Company Treatment of sleep disorders
CA2175939C (en) * 1996-05-07 1999-09-14 Michael Warnett Hetherington Manual capsule filling device
ES2227707T3 (es) * 1996-07-15 2005-04-01 Alza Corporation Nuevas formulaciones para la administracion transdermica de acetato de fluoxetina y de maleato de fluoxetina.
US5830500A (en) * 1996-07-22 1998-11-03 Pentech Pharmaceuticals, Inc. Low dose fluoxetine tablet

Also Published As

Publication number Publication date
EP1067918A1 (en) 2001-01-17
CA2325858A1 (en) 1999-10-07
WO1999049857A1 (en) 1999-10-07
BR9909118A (pt) 2001-10-16
AU3205399A (en) 1999-10-18
JP2002509882A (ja) 2002-04-02
US20030013740A1 (en) 2003-01-16
KR20010034703A (ko) 2001-04-25
NO20004818D0 (no) 2000-09-26
CN1303280A (zh) 2001-07-11
NO20004818L (no) 2000-11-23

Similar Documents

Publication Publication Date Title
ZA200005189B (en) Stable dosage forms of fluoxetine and its enantiomers.
ZA200110022B (en) Thiazoloderivatives and pharmaceutical compositions containing them.
ZA991951B (en) Compound and its use.
ZA200003392B (en) Cutting elements and methods of manufacture thereof.
ZA200107870B (en) Fused-ring compounds and use thereof.
HK1049630A1 (en) Highly selective norepinephrine reuptake inhibitors and methods of using the same.
ZA200203316B (en) New use and novel n-azabicyclo-amide derivatives.
ZA99454B (en) Novel dosage form.
HUP0103884A3 (en) Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use
MXPA01012104A (es) Electrocatalizador de rodio y metodos de preparacion.
EP1112252A4 (en) KAPPA AGONIST COMPOUNDS AND PHARMACEUTICAL FORMULATIONS THEREOF
PL351250A1 (en) Antipicornaviral compounds, their preparation and use
IL143221A0 (en) Combination of cerivastatin and fibrates
HK1048318B (zh) 取代的3-苯基-5-烷氧基-1，3，4-噁二唑-2-酮及其作為脂酶抑制劑的用途
ZA991232B (en) New compound and pharmaceutical compositions thereof.
ZA200006020B (en) Voacamine as anti-malarial agent and anti-malarial agent containing voacamine.
ZA985709B (en) Encapsulated solution dosage forms of sertraline.
HUP0104723A3 (en) New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use
ZA200109120B (en) Use of Arylalkanoylpyridazines.
HUP0103006A3 (en) Substituted betha-diketones, pharmaceutical compositions containing them and their use
ZA99835B (en) Preparation of microballoons.
GB9805464D0 (en) Construction of ioniser
ZA200110325B (en) Highly selective norepinephrine reuptake inhibitors and methods of using the same.
ZA995435B (en) Prestressing of supports.
EG23239A (en) Preparation of haemagel.